leadf
logo-loader
ASX:IMU PINK:IUGNF

Imugene Ltd

Receive alerts
Market:
ASX
Market Cap:
$497.8 m
Price
0.11 AUD
Change
-4.55%
52 weeks high
0.14
52 weeks low
0.02

In brief

Imugene Ltd (ASX:IMU) is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors.

Snapshot

The company is well-funded to deliver on commercial and clinical milestones including the development of CF33, PD1-Vaxx and HER-Vaxx treatments.